Proof of Concept study for the development of a biosimilar monoclonal antibody using the Quality by Design (QbD) approach.
The project proposal is dealing with the development of a biosimilar Mab up to the stage of proof of concept. We propose a typical QbD approach for the development of our biosimilar Mab as is described in the recently published ‘A-Mab: a Case Study in Bioprocess Development’.
1 556 200.00€
BIOLOGICAL SCIENCES / TECHNOLOGIES
MEDICAL / HEALTH RELATED